Src-mediated pathways regulating adherens junction assembly.
Src 介导的途径调节粘附连接组装。
基本信息
- 批准号:10166863
- 负责人:
- 金额:$ 31.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAddressAdherens JunctionBCAR1 geneBindingBlood VesselsCell-Cell AdhesionCell-Matrix JunctionCellsComplexDataEndothelial CellsEndotheliumEngineeringEventExhibitsExtracellular MatrixExtravasationFocal AdhesionsGoalsGuanine Nucleotide Exchange FactorsGuanosine TriphosphateGuanosine Triphosphate PhosphohydrolasesIndividualIntegral Membrane ProteinLocationMediatingMembraneModelingMolecularMonomeric GTP-Binding ProteinsMorphologyPTK2 genePathologicPathway interactionsPermeabilityPhosphorylationPhosphorylation SitePlayProcessProtein EngineeringProteinsRegulationRoleSRC geneSignal PathwaySignal TransductionSiteStructureTestingVascular Endotheliumbasecadherin 5novelprotein-tyrosine kinase c-srcrecruitsrc-Family Kinasestool
项目摘要
Project Summary
Endothelial barrier is regulated at the level of adherens junctions (AJs), cell-cell adhesion structures mediated
by the transmembrane protein VE-cadherin. Current model suggests that the tyrosine kinase c-Src functions as
a negative regulator of endothelial barrier stimulating disassembly of AJs through phosphorylation of VE
cadherin. However, our studies challenge this paradigm. We found that direct activation of Src using our
engineered probe transiently enhances barrier function and induces formation of morphologically distinct AJs
that exhibit reduced permeability. Our preliminary evidence suggests that Src-induced enhancement of
endothelial barrier is mediated through signaling pathway regulating small GTPase Arf6. We also found that
phosphorylation of VE cadherin on Tyr658/Tyr731 is critical for barrier strengthening by Src. Our studies also
show that Src promotes formation of new contacts with extracellular matrix (focal adhesions) and stimulates
interaction of focal adhesion protein p130Cas with VE cadherin. Based on these novel findings we hypothesize
that Src signaling though Arf6 and VE-cadherin, and stimulation of new focal adhesions promote formation of
AJs leading to strengthening of endothelial barrier. To define the role of each pathway downstream of Src, we
propose to address the following questions. 1) We will determine the role of Arf6 activity in Src-stimulated
formation of AJs, and identify Src-mediated pathways that activate Arf6. 2) We will define the role of Src
signaling in AJs and the role of individual phosphorylation sites on VE-cadherin in formation of new AJs and
enhancement of endothelial permeability. 3) We will determine the role of focal adhesions in Src-mediated
enhancement of endothelial barrier and define the role of Src signaling through specific focal adhesion
proteins. The timing and location of Src-mediated signaling is critical for regulation of AJs. Thus, to achieve
precise temporal and spatial control of Src-mediated processes regulating AJs, we propose to employ
engineered protein tools that will allow us to regulate precisely the activity of Src and phosphorylation of VE-
cadherin in living cells. The level of control is unprecedented in that Src can be selectively activated and
inactivated with tight temporal control and in specific subcellular locations in living cells. Importantly, Src
activation can be restricted to a specific downstream targets and subcellular locations. Using these tools, we
will dissect individual Src-mediated signaling pathways controlling assembly of AJs.
项目摘要
内皮屏障在黏附连接(AJs)水平上被调节,细胞-细胞黏附结构介导
通过跨膜蛋白VE-钙粘附素。目前的模型表明,酪氨酸激酶c-Src的功能是
内皮屏障负性调节因子通过VE的磷酸化刺激AJs的分解
钙粘附素。然而,我们的研究挑战了这一范式。我们发现,使用我们的
工程探针瞬时增强屏障功能并诱导形态不同的AJ形成
表现出渗透性降低的情况。我们的初步证据表明,Src诱导的增强
内皮屏障是通过调节小GTP酶Arf6的信号通路介导的。我们还发现,
Tyr658/Tyr731上VE钙粘附素的磷酸化是Src增强屏障的关键。我们的研究也
显示Src促进与细胞外基质形成新的接触(局灶性粘连)并刺激
粘着斑蛋白p130Cas与VE钙粘附素的相互作用基于这些新发现,我们假设
通过Arf6和VE-cadherin的Src信号转导,以及对新的局部粘连的刺激,促进了
AJS导致内皮屏障增强。为了定义Src下游的每条路径的作用,我们
建议解决以下问题。1)我们将确定Arf6活性在Src刺激中的作用
AJs的形成,并确定Src介导的激活Arf6的途径。2)我们将定义服务提供商的角色
AJs中的信号转导及VE-cadherin上单个磷酸化位点在新AJs和AJs形成中的作用
内皮通透性增强。3)我们将确定局部粘连在Src介导的过程中的作用
血管内皮细胞屏障的增强和通过特异的局部黏附确定Src信号的作用
蛋白质。Src介导的信号转导的时间和位置对AJ的调控至关重要。因此,要实现
精确的时间和空间控制的src介导的过程调节的AJ,我们建议使用
工程蛋白质工具,将使我们能够精确地调节Src的活性和VE的磷酸化-
活细胞中的钙粘附素。控制级别是史无前例的,因为可以选择性地激活和
在严格的时间控制和活细胞中特定的亚细胞位置失活。重要的是,源
激活可以被限制在特定的下游靶点和亚细胞位置。使用这些工具,我们
将剖析控制AJ组装的单个Src介导的信号通路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREI V KARGINOV其他文献
ANDREI V KARGINOV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREI V KARGINOV', 18)}}的其他基金
Optogenetic Control of Tumor Initiation and Tumor Progression in vivo
体内肿瘤发生和进展的光遗传学控制
- 批准号:
10640927 - 财政年份:2022
- 资助金额:
$ 31.38万 - 项目类别:
Regulation of endothelial cell invasion, migration and cell junction plasticity
内皮细胞侵袭、迁移和细胞连接可塑性的调节
- 批准号:
10406685 - 财政年份:2022
- 资助金额:
$ 31.38万 - 项目类别:
Optogenetic Control of Tumor Initiation and Tumor Progression in vivo
体内肿瘤发生和进展的光遗传学控制
- 批准号:
10413468 - 财政年份:2022
- 资助金额:
$ 31.38万 - 项目类别:
Regulation of endothelial cell invasion, migration and cell junction plasticity
内皮细胞侵袭、迁移和细胞连接可塑性的调节
- 批准号:
10685981 - 财政年份:2022
- 资助金额:
$ 31.38万 - 项目类别:
Optogenetic tools for the dissection of oncogenic signaling mediated by kinases
用于解析激酶介导的致癌信号的光遗传学工具
- 批准号:
9891973 - 财政年份:2018
- 资助金额:
$ 31.38万 - 项目类别:
Src-mediated pathways regulating adherens junction assembly.
Src 介导的途径调节粘附连接组装。
- 批准号:
9310733 - 财政年份:2017
- 资助金额:
$ 31.38万 - 项目类别:
New methods for activation of kinases and kinase circuits in living cells.
激活活细胞中激酶和激酶电路的新方法。
- 批准号:
8243734 - 财政年份:2012
- 资助金额:
$ 31.38万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.38万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.38万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.38万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.38万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.38万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.38万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.38万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.38万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.38万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.38万 - 项目类别:
Research Grant